# Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication

**Authors:** Kaijing Liu, Lilija Wehling, Shan Wan, Sofia M. E. Weiler, Marcell Tóth, David Ibberson, Silke Marhenke, Adnan Ali, Macrina Lam, Te Guo, Federico Pinna, Fabiola Pedrini, Amruta Damle-Vartak, Anne Dropmann, Fabian Rose, Silvia Colucci, Wenxiang Cheng, Michaela Bissinger, Jennifer Schmitt, Patrizia Birner, Tanja Poth, Peter Angel, Steven Dooley, Martina U. Muckenthaler, Thomas Longerich, Arndt Vogel, Mathias Heikenwälder, Peter Schirmacher, Kai Breuhahn

PMC · DOI: 10.1007/s00018-024-05126-1 · Cellular and Molecular Life Sciences · 2024-03-04

## TL;DR

This study shows that YAP inactivation in liver cells causes damage, and YAP activation in non-parenchymal cells promotes inflammation through secreted factors.

## Contribution

A new mechanism is revealed where YAP in non-parenchymal liver cells controls cell communication and inflammation.

## Key findings

- YAP inactivation in hepatocytes and biliary cells leads to liver damage and fibrosis.
- TAZ deletion reduces the severity of liver damage caused by YAP inactivation.
- YAP activation in non-parenchymal cells increases secretion of pro-inflammatory molecules like CXCL11 and ICAM1.

## Abstract

The Hippo pathway and its transcriptional effectors yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are targets for cancer therapy. It is important to determine if the activation of one factor compensates for the inhibition of the other. Moreover, it is unknown if YAP/TAZ-directed perturbation affects cell–cell communication of non-malignant liver cells.

To investigate liver-specific phenotypes caused by YAP and TAZ inactivation, we generated mice with hepatocyte (HC) and biliary epithelial cell (BEC)-specific deletions for both factors (YAPKO, TAZKO and double knock-out (DKO)). Immunohistochemistry, single-cell sequencing, and proteomics were used to analyze liver tissues and serum.

The loss of BECs, liver fibrosis, and necrosis characterized livers from YAPKO and DKO mice. This phenotype was weakened in DKO tissues compared to specimens from YAPKO animals. After depletion of YAP in HCs and BECs, YAP expression was induced in non-parenchymal cells (NPCs) in a cholestasis-independent manner. YAP positivity was detected in subgroups of Kupffer cells (KCs) and endothelial cells (ECs). The secretion of pro-inflammatory chemokines and cytokines such as C-X-C motif chemokine ligand 11 (CXCL11), fms-related receptor tyrosine kinase 3 ligand (FLT3L), and soluble intercellular adhesion molecule-1 (ICAM1) was increased in the serum of YAPKO animals. YAP activation in NPCs could contribute to inflammation via TEA domain transcription factor (TEAD)-dependent transcriptional regulation of secreted factors.

YAP inactivation in HCs and BECs causes liver damage, and concomitant TAZ deletion does not enhance but reduces this phenotype. Additionally, we present a new mechanism by which YAP contributes to cell–cell communication originating from NPCs.

The online version contains supplementary material available at 10.1007/s00018-024-05126-1.

## Linked entities

- **Genes:** YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901], CXCL11 (C-X-C motif chemokine ligand 11) [NCBI Gene 6373], FLT3LG (fms related receptor tyrosine kinase 3 ligand) [NCBI Gene 2323], ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383], sd (scalloped) [NCBI Gene 32536]

## Full-text entities

- **Genes:** Cxcl11 (chemokine (C-X-C motif) ligand 11) [NCBI Gene 56066] {aka Cxc11, H174, I-tac, Ip9, Itac, Scyb11}, Icam1 (intercellular adhesion molecule 1) [NCBI Gene 15894] {aka CD54, Icam-1, Ly-47, MALA-2}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Flt3l (FMS-like tyrosine kinase 3 ligand) [NCBI Gene 14256] {aka Flt3lg, Ly72L}
- **Diseases:** inflammation (MESH:D007249), necrosis (MESH:D009336), cancer (MESH:D009369), liver fibrosis (MESH:D008103), liver damage (MESH:D056486), cholestasis (MESH:D002779)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10912141/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10912141/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC10912141/full.md

---
Source: https://tomesphere.com/paper/PMC10912141